ESR1 and breast cancer: To validate the ability of this assay to detect ADAM8 expression in tissue samples, a set of tissue microarrays (TMAs) with 490 breast cancer biopsies, including 412 with data on expression of ER, PR and HER2 (including 61 TNBCs across the panel), were analyzed.